Edward Cha

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label,…

The Lancet · 2023 · 469 citations

Improved survival with T cell clonotype stability after anti-CTLA-4 treatment in cancer patients

Science Translational Medicine · 2014 · First of 7 authors · 337 citations